894 related articles for article (PubMed ID: 26153346)
1. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
[TBL] [Abstract][Full Text] [Related]
2. LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression.
Liu W; Dai Q; Lu N; Wei L; Ha J; Rong J; Mu R; You Q; Li Z; Guo Q
Biochem Cell Biol; 2011 Jun; 89(3):287-98. PubMed ID: 21491996
[TBL] [Abstract][Full Text] [Related]
3. LYG-202, a new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro.
Zeng S; Liu W; Nie FF; Zhao Q; Rong JJ; Wang J; Tao L; Qi Q; Lu N; Li ZY; Guo QL
Biochem Biophys Res Commun; 2009 Aug; 385(4):551-6. PubMed ID: 19481059
[TBL] [Abstract][Full Text] [Related]
4. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
5. A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway.
Guo CL; Wang LJ; Zhao Y; Liu H; Li XQ; Jiang B; Luo J; Guo SJ; Wu N; Shi DY
Mar Drugs; 2018 Jan; 16(2):. PubMed ID: 29370087
[TBL] [Abstract][Full Text] [Related]
6. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
[TBL] [Abstract][Full Text] [Related]
7. Furazolidone induces apoptosis through activating reactive oxygen species-dependent mitochondrial signaling pathway and suppressing PI3K/Akt signaling pathway in HepG2 cells.
Deng S; Tang S; Zhang S; Zhang C; Wang C; Zhou Y; Dai C; Xiao X
Food Chem Toxicol; 2015 Jan; 75():173-86. PubMed ID: 25434308
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG(2) cells.
Chen FH; Zhang LB; Qiang L; Yang Z; Wu T; Zou MJ; Tao L; You QD; Li ZY; Yang Y; Guo QL
Cancer Lett; 2010 Oct; 296(1):96-105. PubMed ID: 20580989
[TBL] [Abstract][Full Text] [Related]
9. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
[TBL] [Abstract][Full Text] [Related]
10. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
Huang J; Yang M; Liu H; Jin J
Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
Chen J; Wang W; Wang H; Liu X; Guo X
Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
[TBL] [Abstract][Full Text] [Related]
12. LW-214, a newly synthesized flavonoid, induces intrinsic apoptosis pathway by down-regulating Trx-1 in MCF-7 human breast cells.
Pan D; Li W; Miao H; Yao J; Li Z; Wei L; Zhao L; Guo Q
Biochem Pharmacol; 2014 Feb; 87(4):598-610. PubMed ID: 24374359
[TBL] [Abstract][Full Text] [Related]
13. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway.
Han B; Jiang P; Li Z; Yu Y; Huang T; Ye X; Li X
Phytomedicine; 2018 Sep; 48():152-160. PubMed ID: 30195873
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
Hong Y; Fan D
Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
[TBL] [Abstract][Full Text] [Related]
17. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway.
Wang G; Lu M; Yao Y; Wang J; Li J
Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.
Laezza C; Malfitano AM; Di Matola T; Ricchi P; Bifulco M
Mol Carcinog; 2010 Oct; 49(10):892-901. PubMed ID: 20672320
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
20. A novel derivative of quinazoline, WYK431 induces G2/M phase arrest and apoptosis in human gastric cancer BGC823 cells through the PI3K/Akt pathway.
Wang TE; Wang YK; Jin J; Xu BL; Chen XG
Int J Oncol; 2014 Aug; 45(2):771-81. PubMed ID: 24859921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
